Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage

Journal of Pharmacological Sciences

Volumn 115, Issue 2, 2011, Pages 155-163

  Harada, Shinichi ^a   Fujita Hamabe, Wakako ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; Gluconeogenesis; Glucose intolerance; Insulin receptor; Orexin A

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN RECEPTOR; OREXIN A; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIVER; MALE; MEMORY DISORDER; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; SKELETAL MUSCLE;

EID: 79952333129     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10264FP     Document Type: Article

References (36)

1. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet. 1999;354:1457-1463. (Pubitemid 29494766)
2. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke. 2007;38: 2992-2999. (Pubitemid 350035695)
3. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, et al. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med. 2005;165:227-233.
4. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 1993;24:111-116. (Pubitemid 23014392)
5. Widmer H, Abiko H, Faden AI, James TL, Weinstein PR. Effects of hyperglycemia on the time course of change in energy metabolism and pH during global cerebral ischemia and reperfusion in rats. J Cereb Blood Flow Metab. 1992;12:456-468.
6. Olsson T, Viitanen M, Asplund K, Eriksson S, Hägg E. Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia. 1990;33:244-249.
7. Harada S, Fujita-Hamabe W, Shichi K, Tokuyama S. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res. 2009;1279: 174-181.
8. Harada S, Fujita-Hamabe W, Tokuyama S. The importance of regulation of blood glucose levels through activation of peripheral 5′-AMP-activated protein kinase on ischemic neuronal damage. Brain Res. 2010;1351:254-263.
9. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998;95: 322-327. (Pubitemid 28103952)
10. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:73-85.
11. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;3:171-181. (Pubitemid 46294664)
12. Shiuchi T, Haque MS, Okamoto S, Inoue T, Kageyama H, Lee S, et al. Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system. Cell Metab. 2009;10:466-480.
13. Imai J, Katagiri H, Yamada T, Ishigaki Y, Suzuki T, Kudo H, et al. Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science. 2008;322:1250-1254.
14. Friedman FM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-770. (Pubitemid 28485436)
15. Uyama N, Geerts A, Reynaert H. Neural connections between the hypothalamus and the liver. Anat Rec A Discov Mol Cell Evol Biol. 2004;280:808-820. (Pubitemid 39330960)
16. Yamada T, Katagiri H. Avenues of communication between the brain and tissues/organs involved in energy homeostasis. Endocr. 2007;54:497-505. (Pubitemid 47414595)
17. Irving EA, Harrison DC, Babbs AJ, Mayes AC, Campbell CA, Hunter AJ, et al. Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett. 2009;324:53-56.
18. Mihara Y, Dohi K, Yofu S, Nakamachi T, Ohtaki H, Shioda S, et al. Expression and localization of the orexin-1 receptor (OX1R) after traumatic brain injury in mice. J Mol Neurosci. In press 2010.
19. Kitamura E, Hamada J, Kanazawa N, Yonekura J, Masuda R, Sakai F, et al. The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res. 2010;68: 154-157.
20. Harada S, Hamabe W, Kamiya K, Satake T, Yamamoto J, Tokuyama S. Preventive effect of Morinda citrifolia fruit juice on neuronal damage induced by focal ischemia. Biol Pharm Bull. 2009;32:405-409.
21. Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother. 1957;12:12-15.
22. Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates. 3rd ed. New York: Academic Press; 2008.
23. Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008;114: 183-194. (Pubitemid 352009305)
24. Li S, Brown MS, Goldstein JL. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A. 2010;107:3441-3446.
25. Prasad RC, Herzog B, Boone B, Sims L, Waltner-Law M. An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes. J Ethnopharmacol. 2005;96: 295-301. (Pubitemid 39575063)
26. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001;435:6-25. (Pubitemid 32448719)
27. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998;438:71-75. (Pubitemid 28517837)
28. Shimazu T, Ogasawara S. Effects of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver. Am J Physiol. 1975; 228:1787-1793.
29. 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur J Neurosci. 2004;19:1524-1534.
30. Takenoya F, Kageyama H, Shiba K, Date Y, Nakazato M, Shioda S. Neuropeptide W: a key player in the homeostatic regulation of feeding and energy metabolism? Ann N Y Acad Sci. 2010;1200: 162-169.
31. Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 2000;859:404-409. (Pubitemid 30136120)
32. Gyte A, Pritchard LE, Jones HB, Brennand JC, White A. Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats. J Neuroendocrinol. 2007;19:941-951. (Pubitemid 350131080)
33. Mizuno TM, Kelley KA, Pasinetti GM, Roberts JL, Mobbs CV. Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes. 2003;52: 2675-2683. (Pubitemid 37339696)
34. Tsuneki H, Murata S, Anzawa Y, Soeda Y, Tokai E, Wada T, et al. Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice. Diabetologia. 2008;51:657-667.
35. Tsuneki H, Wada T, Sasaoka T. Role of orexin in the regulation of glucose homeostasis. Acta Physiol (Oxf). 2010;198:335-348.
36. Nakamachi T, Endo S, Ohtaki H, Yin L, Kenji D, Kudo Y, et al. Orexin-1 receptor expression after global ischemia in mice. Regul Pept. 2005;126:49-54. (Pubitemid 40037742)